Breye Therapeutics
9 known investors
Find your way into Breye Therapeutics
Sign up to see every warm intro you have to Breye Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Breye Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Breye Therapeutics is a biopharmaceutical company developing medicines for ophthalmologic and metabolic diseases, leveraging expertise in clinical development, manufacturing, and regulatory pathways. The company focuses on bringing novel therapies from early-stage discovery through late-stage development and product approval.
Founders & leadership
Investors · 9
How we know: the company's own site · uk.finance.yahoo.com · Not right? Tell us
How we know: Modi Ventures's portfolio page · uk.finance.yahoo.com · Not right? Tell us
How we know: Sound Bioventures's portfolio page · uk.finance.yahoo.com · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$67.5M disclosed across 1 round · 2026
- $67.5MSeries AOct 2026 · 3 sources
Mission BioCapital (lead), Novo Holdings (lead), Catalyze Capital, EIFO, Innovestor Life Science, Ljungström family office, Modi Ventures, Pappas Capital, Sound Bioventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Breye raises €67.5M for diabetic eye disease trial with Novo Holdings backingeuropean-biotechnology.com · Oct 2026
Breye Therapeutics raises €67.5 million in over-subscribed Series A financinguk.finance.yahoo.com · Oct 2026Frequently asked questions
- What does Breye Therapeutics do?
- Breye Therapeutics is a biopharmaceutical company developing medicines for ophthalmologic and metabolic diseases, leveraging expertise in clinical development, manufacturing, and regulatory pathways. The company focuses on bringing novel therapies from early-stage discovery through late-stage development and product approval.
- Who are Breye Therapeutics's investors?
- Breye Therapeutics's investors include Novo Holdings, Modi Ventures, Sound Bioventures, Catalyze Capital, Mission Biocapital, Pappas Capital.
- How much funding has Breye Therapeutics raised?
- Breye Therapeutics has disclosed $67.5M raised across 1 round.
